WebDisclosure WebDisclosure
Basculer en Français
10091 Companies
206512 Keywords
136684 Articles
109461 Press releases
Headlines Articles Press releases CYPRUMED GmbH Remove
  1. Home
  2. Companies
  3. CYPRUMED GmbH
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/15/2025 at 09:05, 11 months 10 days ago

    Cyprumed Partners with MSD on Oral Peptide Therapeutics

    Drug Delivery Technology License Agreement Cyprumed MSD Partnership Oral Peptide Therapeutics
  • BRIEF

    published on 04/15/2025 at 09:05, 11 months 10 days ago

    Cyprumed s'associe à MSD pour développer des thérapies peptidiques orales

    Technologie D'administration De Médicaments Accord De Licence Cyprumé Partenariat MSD Thérapies Peptidiques Orales
  • PRESS RELEASE

    published on 04/15/2025 at 09:00, 11 months 10 days ago

    Cyprumed Enters License and Option Agreement with MSD for the Development of Oral Peptide Therapeutics

    Cyprumed and MSD sign a Non-Exclusive License and Option Agreement for the Development of Oral Peptide Therapeutics, potentially unlocking new opportunities in peptide therapeutics
    Drug Delivery Technology License Agreement Cyprumed Oral Peptide Therapeutics MSD
    Logo of CYPRUMED GmbH
Accesswire
  • Published on 03/26/2026 at 00:40, 3 hours 57 minutes ago

    Challenger RC Resource Upgrade Drilling Complete

  • Published on 03/26/2026 at 00:30, 4 hours 7 minutes ago

    Nano One Highlights Recent Objectives & Reports Fourth Quarter 2025 Results

  • Published on 03/25/2026 at 19:15, 9 hours 22 minutes ago

    Gemina Laboratories Ltd. Announces Delisting from the CSE

  • Published on 03/25/2026 at 13:30, 15 hours 7 minutes ago

    Prince Silver Files NI 43-101 Technical Report for Its Stampede Gap Porphyry Copper-Gold-Molybdenum Project in Nevada

  • Published on 03/25/2026 at 13:30, 15 hours 7 minutes ago

    Triera Biosciences - a Zentek Company - Launches Contract Research Organization Services for Custom Aptamer Discovery, Biosensor Enablement, and Machine-Learning Classification

View all ACCESSWIRE
EQS Group
  • Published on 03/26/2026 at 01:05, 3 hours 31 minutes ago

    Blokees Announces Upgrade Brand Mission at 2026 Global Partner Conference

  • Published on 03/25/2026 at 20:00, 8 hours 36 minutes ago

    Piramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet Press

  • Published on 03/25/2026 at 19:41, 8 hours 56 minutes ago

    EQS-Adhoc: STRATEC POSTS IMPAIRMENTS, REPORTS PRELIMINARY RESULTS FOR 2025, AND OFFERS GUIDANCE FOR 2026

  • Published on 03/25/2026 at 19:30, 9 hours 7 minutes ago

    AIXTRON to expand global footprint with new plant in Malaysia

  • Published on 03/25/2026 at 19:26, 9 hours 10 minutes ago

    EQS-Adhoc: AIXTRON SE to expand global footprint with new plant in Malaysia

View all EQS
Les Echos
  • Published on 03/25/2026 at 18:53, 9 hours 43 minutes ago

    CIS - Transfert Contrat de Liquidité Portzamparc - 25.03.2026

  • Published on 03/25/2026 at 18:53, 9 hours 43 minutes ago

    LNA SANTE : 2025 Annual Results

  • Published on 03/25/2026 at 18:31, 10 hours 6 minutes ago

    Strong investment performance and active roll-out of our strategy

  • Published on 03/25/2026 at 18:31, 10 hours 6 minutes ago

    Performance soutenue des Investissements et déploiement actif de la stratégie

  • Published on 03/25/2026 at 18:06, 10 hours 30 minutes ago

    LNA SANTE : Résultats Annuels 2025

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy